Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Nakhonpathom, Thailand.
Chulabhorn Graduate Institute, Chulabhorn Royal Academy, Bangkok, Thailand.
J Pineal Res. 2018 May;64(4):e12470. doi: 10.1111/jpi.12470. Epub 2018 Feb 8.
Melatonin is involved in the physiological regulation of the β-amyloid precursor protein (βAPP)-cleaving secretases which are responsible for generation of the neurotoxic amyloid beta (Aβ) peptide, one of the hallmarks of Alzheimer's disease (AD) pathology. In this study, we aimed to determine the underlying mechanisms of this regulation under pathological conditions. We establish that melatonin prevents Aβ -induced downregulation of a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) as well as upregulation of β-site APP-cleaving enzyme 1 (BACE1) and presenilin 1 (PS1) in SH-SY5Y cell cultures. We also demonstrate that the intrinsic mechanisms of the observed effects occurred via regulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and glycogen synthase kinase (GSK)-3β as melatonin reversed Aβ -induced upregulation and nuclear translocation of NF-κBp65 as well as activation of GSK3β via its receptor activation. Furthermore, specific blocking of the NF-κB and GSK3β pathways partially abrogated the Aβ -induced reduction in the BACE1 and PS1 levels. In addition, GSK3β blockage affected α-secretase cleavage and modulated nuclear translocation of NF-κB. Importantly, our study for the first time shows that peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) is a crucial target of melatonin. The compromised levels and/or genetic variation of Pin1 are associated with age-dependent tau and Aβ pathologies and neuronal degeneration. Interestingly, melatonin alleviated the Aβ -induced reduction of nuclear Pin1 levels and preserved the functional integrity of this isomerase. Our findings illustrate that melatonin attenuates Aβ -induced alterations of βAPP-cleaving secretases possibly via the Pin1/GSK3β/NF-κB pathway.
褪黑素参与β-淀粉样前体蛋白(βAPP)裂解酶的生理调节,这些酶负责生成神经毒性淀粉样β(Aβ)肽,这是阿尔茨海默病(AD)病理学的标志之一。在这项研究中,我们旨在确定这种调节在病理条件下的潜在机制。我们确定褪黑素可防止 Aβ 诱导的去整合素和金属蛋白酶域蛋白 10(ADAM10)下调以及β-位点 APP 裂解酶 1(BACE1)和早老素 1(PS1)上调在 SH-SY5Y 细胞培养物中。我们还证明,观察到的效应的内在机制是通过调节核因子κ轻链增强子的激活 B 细胞(NF-κB)和糖原合酶激酶(GSK)-3β发生的,因为褪黑素逆转了 Aβ 诱导的 NF-κBp65的上调和核易位以及通过其受体激活对 GSK3β的激活。此外,NF-κB 和 GSK3β 途径的特异性阻断部分阻断了 Aβ 诱导的 BACE1 和 PS1 水平降低。此外,GSK3β 阻断影响 α-分泌酶切割并调节 NF-κB 的核易位。重要的是,我们的研究首次表明,肽基脯氨酰顺反异构酶 NIMA 相互作用 1(Pin1)是褪黑素的关键靶标。Pin1 的受损水平和/或遗传变异与年龄依赖性 tau 和 Aβ 病理学和神经元变性有关。有趣的是,褪黑素减轻了 Aβ 诱导的核 Pin1 水平降低,并保持了这种异构酶的功能完整性。我们的研究结果表明,褪黑素通过 Pin1/GSK3β/NF-κB 途径减轻 Aβ 诱导的βAPP 裂解酶的改变。